Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07075133

Chrono-restricted Diet and Physical Activity as a New Preventive Strategy for Sarcopenia in Postmenopausal Women With Obesity and Type 2 Diabetes

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
45 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim of TIMEDIAB is to demonstrate that early TRE (eTRE) combined to late (afternoon) exercise will outperform eTRE combined to morning exercise on muscle function as primary endpoint, and glucose homeostasis as secondary endpoint

Detailed description

Overweight, obesity, aging and menopause are all independent risk factors in the development of type 2 diabetes mellitus (T2DM). Older women with T2DM are at especially high risk for sarcopenia, i.e. loss of skeletal muscle mass and force, and cardiovascular diseases. The first line of T2DM treatment is based on lifestyle changes including weight loss and physical activity. One major current medical challenge is to find novel lifestyle therapies able to reduce cardiometabolic risk while perserving muscle mass in obese older individuals. As a result, intermittent fasting approaches, including time-restricted feeding/eating (TRF/TRE), have been offered as alternative dietary strategies that may have beneficial effects on weight control and T2DM. It has been recently observed that long-term TRF improve glucose homeostasis while perserving muscle mass and force in female obese mice. The purpose of TIMEDIAB is to demonstrate that early TRE (eTRE) combined to late (afternoon) exercise will outperform eTRE combined to morning exercise on various components of muscle health as primary endpoint, and blood glucose control, body composition, energy balance, cardiovascular risk, and metabolic health as secondary endpoints. This study will pave the way to larger scale randomized clinical trials investigating the long-term effects/benefits of such intervention and in other target populations.

Conditions

Interventions

TypeNameDescription
OTHERAntidiabetic diet (control)Standard antidiabetic diet
OTHEReTRE dieteTRE for a total duration of 12 weeks. During the eTRE, volunteers will have to eat and drink (meals + snacks, medication) exclusively during an 8-hour period which will extend between 6 a.m. (flexible: or 7 a.m. or 8 a.m.) in the morning and 2 p.m. (depending on the chosen start time: or 3 p.m. or 4 p.m.), which corresponds to a fasting period of 16 hours per day
OTHERPhysical activity in the morningPhysical exercise will consist of 3 weekly morning sessions that will combine aerobic and resistance exercises
OTHERPhysical activity in the afternoonThe physical exercise will consist of 3 weekly afternoon sessions that will combine aerobic and resistance exercises.

Timeline

Start date
2025-07-15
Primary completion
2029-07-15
Completion
2029-07-15
First posted
2025-07-20
Last updated
2025-07-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07075133. Inclusion in this directory is not an endorsement.